GPC6-AS2: A Potential Drug Target and Biomarker (G100873973)
GPC6-AS2: A Potential Drug Target and Biomarker
Glycophosphorylase 6 (GPC6) is a protein that is expressed in various tissues and cells throughout the body. It is a key enzyme in the GPC6 pathway, which is a metabolic pathway that is involved in the biosynthesis of many different molecules. One of the unique features of GPC6 is that it can interact with another protein called AS2. AS2 is a scaffold protein that is involved in the regulation of cellular processes such as cell adhesion, migration, and invasion. The interaction between GPC6 and AS2 has been observed to be important for the regulation of cellular processes, and as a result, GPC6 has been identified as a potential drug target and biomarker.
The GPC6 pathway is involved in the biosynthesis of many different molecules, including nucleotides, lipids, and proteins. This pathway is critical for the growth, development, and survival of all living organisms. GPC6 is a key enzyme in this pathway, and it catalyzes the conversion of the precursor nucleotides G4 and P1 into the final products.
GPC6 has been shown to play a role in many different cellular processes. For example, GPC6 has been shown to be involved in the regulation of cell adhesion. Many different cell types have the ability to stick to each other and to other surfaces, and this process is critical for the proper functioning of cells. GPC6 is involved in this process by catalyzing the conversion of the adhesion molecules integrins into the cell surface. This allows the cells to stick together and form tissues.
GPC6 has also been shown to be involved in the regulation of cell migration. Cells have the ability to move from one location to another in order to divide, migrate, or respond to changes in the environment. GPC6 is involved in this process by catalyzing the conversion of the protein vimentin into a hydrophilic form. This allows the vimentin protein to interact with the cytoskeleton and help to regulate the movement of the cell.
In addition to its role in cell adhesion and migration, GPC6 has also been shown to be involved in the regulation of many other cellular processes. For example, GPC6 has been shown to be involved in the regulation of cell signaling pathways. This includes the regulation of angiogenesis, the formation of new blood vessels, and the regulation of cell proliferation.
GPC6 has also been shown to play a role in the regulation of inflammation. Many different types of inflammation are harmful to the body, and it is important to have mechanisms in place to regulate and control these processes. GPC6 is involved in this process by catalyzing the conversion of the enzyme cyclophosphamide into a less toxic form. This allows the cyclophosphamide to be used as an anti-inflammatory drug.
GPC6 has also been shown to play a role in the regulation of the immune response. This includes the regulation of the production of antibodies, the activation of T cells, and the regulation of the complement system.
In conclusion, GPC6 is a protein that is involved in many different cellular processes. Its unique interaction with AS2 has been observed to be important for the regulation of cellular processes, and as a result, GPC6 has been identified as a potential drug target and biomarker. Further research is needed to fully understand the role of GPC6 in cellular processes and its potential as a drug.
Protein Name: GPC6 Antisense RNA 2
The "GPC6-AS2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GPC6-AS2 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
GPCPD1 | GPD1 | GPD1L | GPD2 | GPER1 | GPHA2 | GPHB5 | GPHN | GPI | GPI transamidase complex | GPI-GlcNAc transferase complex | GPIHBP1 | GPKOW | GPLD1 | GPM6A | GPM6B | GPN1 | GPN2 | GPN3 | GPNMB | GPR101 | GPR107 | GPR108 | GPR119 | GPR12 | GPR132 | GPR135 | GPR137 | GPR137B | GPR137C | GPR139 | GPR141 | GPR142 | GPR143 | GPR146 | GPR148 | GPR149 | GPR15 | GPR150 | GPR151 | GPR152 | GPR153 | GPR155 | GPR156 | GPR157 | GPR158 | GPR158-AS1 | GPR15LG | GPR160 | GPR161 | GPR162 | GPR17 | GPR171 | GPR173 | GPR174 | GPR176 | GPR179 | GPR18 | GPR180 | GPR182 | GPR183 | GPR19 | GPR199P | GPR20 | GPR21 | GPR22 | GPR25 | GPR26 | GPR27 | GPR3 | GPR31 | GPR32 | GPR33 | GPR34 | GPR35 | GPR37 | GPR37L1 | GPR39 | GPR4 | GPR42 | GPR45 | GPR50 | GPR52 | GPR55 | GPR6 | GPR61 | GPR62 | GPR63 | GPR65 | GPR68 | GPR75 | GPR75-ASB3 | GPR78 | GPR79 | GPR82 | GPR83 | GPR84 | GPR84-AS1 | GPR85 | GPR87
